MODULE XVI (B) – DESCRIPTION
The pathophysiology of hypertension, dyslipidemia, cardiovascular disease and heavy metal toxicity in CVD are explored, as well as methods of patient care through weight management, nutrition and exercise. Also covered are the cardiovascular relationships and clinical presentation of such conditions, in addition to the selection and implementation of laboratory testing and noninvasive diagnostic tests.
MODULE XVI (B) - OBJECTIVES
- Review the underlying causes and mechanisms of dyslipidemia and dyslipidemia-induced cardiovascular disease.
- Understand and apply advanced lipid testing (lipid particle number and size and HDL functionality and quality) for the diagnosis and treatment of dyslipidemia in clinical practice.
- Review the underlying causes and secondary etiologies of dyslipidemia
- Prioritize effective methods to promote vascular repair, reduce vascular damage and define the interrelationships of the cardiovascular system, gastrointestinal tract and microbiome.
- Evaluate nutrition and nutritional supplements to treat dyslipidemia.
- Review 45 new mechanisms involved in dyslipidemia-induced cardiovascular disease and review the integrative therapies.
- Discuss and evaluate Clinical Trials with Statins and other pharmacologic therapies in the primary and secondary treatment of CHD, MI and CVD
- Learn how to apply global cardiovascular risk scoring using the new expanded COSEHC method and others.
- Review Cardiovascular Genomics and SNP’s, the top 5 CHD risk factors [ hypertension, dyslipidemia, (IR, DM, MS, dysglycemia), obesity and smoking], the details of the correct analysis of each, the top 25 modifiable key CHD risk factors and the other 400 CHD risk factors, how to test and their interpretation
- Review finite causes of CHD: inflammation, oxidative stress and immune vascular disease
- Clinical evaluation of chest pain
- Review and understand CHD, MI, CHF and PAD.
- Review metabolic cardiology treatment for CHD, angina and CHF.
- Review selected hormone effects on CHD: cortisol, aldosterone, HPA axis, thyroid and melatonin
- Prioritize which laboratory and non- invasive laboratory and cardiovascular tests should be evaluated in patients in the primary care setting and how to interpret and treat
- Review integrative medical treatments with nutrition, nutritional supplements. Lifestyle, exercise, weight management, sleep, OSA diagnosis and management and drugs for cardiovascular disease with protocols and clinical application
- Review cardiac arrhythmias and cardiac conduction disease: diagnosis, interpretation of testing and treatments with clinical applications and cases.
MODULE XVI (B) - CLINICAL APPLICATIONS
Begin to assess the underlying causes of dyslipidemia such as toxins, infections and nutrition as well as secondary causes
- Order and learn to interpret advanced lipid testing
Begin new treatments based on the 45 mechanisms of lipid induced vascular disease using nutrition, supplements and drugs in an integrative fashion.
Coronary Heart Disease and Congestive Heart Failure
- Measure, treat and clinically apply the top 25 modifiable risk factors and the infinite insults to CVD, CHD and CHF
- Measure, treat and apply the finite responses to CVD of inflammation, oxidative stress and vascular immune dysfuncttion
- Clinically measure, review, interpret and treat the CHD risk factors